In the quantitative studies, a notable trend emerged, with nine studies combining two EORTC instruments: the generic EORTC QLQ-C30 and the tumor-specific EORTC QLQ-GI.NET21, which focuses on muscle and/or bone pain, endocrine and gastrointestinal symptoms, and treatment-related effects ( Supplementary Table S2.4 ).
← all excerpts
Health-Related Quality of Life (HRQoL) Assessments in Research on Patients with Adult Rare Solid Cancers: A State-of-the-Art Review.
1
—
—